Senior Manager, Franchise Communications Respiratory & Immunology
AstraZeneca
Summary
Drive global, integrated communications for AstraZeneca's respiratory and immune-mediated disease portfolio (from Phase IIb onward). Lead external and internal storytelling, and issues management to build reputation, support milestones, and engage collaborators across global, regional, and local offices.
Job description
Job Description Summary
Drive global, integrated communications for AstraZeneca's respiratory and immune-mediated disease portfolio (from Phase IIb onward). Lead external and internal storytelling, and issues management to build reputation, support milestones, and engage collaborators across global, regional, and local offices.
Key Responsibilities
- Strategy & Execution: Develop and deliver global communications plans from Phase 2b through launch with consideration of the full franchise, including milestones, data readouts, regulatory events, congress presence, partnerships and driven responses.
- Narrative & Content: Build compelling disease and asset narratives with clear messages and proof points; produce press releases, Q&As and materials for global and local use; prepare and train spokespeople.
- Stakeholder & Media Engagement: Collaborate with global/regional media and country teams; support investor communications with Investor Relations; engage external experts and investigators.
- Digital & Social: Lead deployment across corporate digital/social channels, employing paid and organic opportunities.
- Internal Communications: Drive internal understanding and engagement for key assets; partner with leaders and Global Internal Communications.
- Program Management: Optimize agencies and resources; set objectives and critical metrics; ensure strong project management and measurement.
Qualifications / Experience
- Education & Experience: Bachelor's degree; 7-10 years in global pharma/life sciences communications.
- Expertise: Proven delivery of strategic programs; understanding of healthcare regulations, compliance, and stakeholder perspectives (physicians, payers, patients).
- Digital & Internal Comms: Strong background in organic/paid digital; effective internal engagement and change communications.
- Collaboration: Demonstrated leadership, coaching ability, and collaborative ways of working.
- Global Mindset: Cultural fluency; combines critical thinking with hands-on delivery; skilled at simplifying scientific/technical content for varied audiences.
Requirements
- Bachelor's degree
- 7-10 years in global pharma/life sciences communications
- Proven delivery of strategic programs
- Understanding of healthcare regulations, compliance, and stakeholder perspectives (physicians, payers, patients)
- Strong background in organic/paid digital
- Effective internal engagement and change communications
- Demonstrated leadership, coaching ability, and collaborative ways of working
- Cultural fluency
- Critical thinking with hands-on delivery
- Skilled at simplifying scientific/technical content for varied audiences
Benefits
- Retirement Programs
- Paid Time Off
- Health Coverage
- Dental Coverage
- Vision Coverage
- Incentive Bonuses
- Equity-Based Awards
Company overview
AstraZeneca is a global, science-led, patient-focused pharmaceutical company dedicated to accelerating the delivery of life-changing medicines that create enduring value for patients, society, and shareholders. With a workforce of over 94,300 employees worldwide, the company operates across three core therapy areas: Oncology, BioPharmaceuticals (including Cardiovascular, Renal & Metabolism, Respiratory & Immunology), and Rare Disease. Headquartered in Cambridge, UK, AstraZeneca maintains strategic R&D centers in Cambridge, Gaithersburg (US), Boston (US), Gothenburg (Sweden), Shanghai, and Beijing. The company generated $54.1 billion in total revenue in 2024 and invested $13.6 billion in scientific research and development. AstraZeneca's bold aspiration is to be pioneers in science, lead in disease areas, and transform patient outcomes, with a goal to launch 20 new medicines and achieve $80 billion in total revenue by 2030. The company is recognized for its commitment to sustainability, health equity, and creating an inclusive work environment where diverse perspectives drive innovation.